Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-03-04 Sale |
2025-03-06 8:30 pm |
Applied Therapeutics Inc. | APLT | Perfetti Riccardo Chief Medical Officer |
10,366 | $0.44 | $4,561 | 890,409 (Direct) |
View |
2025-03-04 Sale |
2025-03-06 8:30 pm |
Applied Therapeutics Inc. | APLT | Funtleyder Leslie D. See Remarks |
14,502 | $0.44 | $6,381 | 390,459 (Direct) |
View |
2025-03-04 Sale |
2025-03-06 8:30 pm |
Applied Therapeutics Inc. | APLT | Chinoporos Constantine See Remarks |
447 | $0.44 | $197 | 271,436 (Direct) |
View |
2025-02-06 Sale |
2025-02-07 8:30 pm |
Applied Therapeutics Inc. | APLT | Funtleyder Leslie D. See Remarks |
22,950 | $0.61 | $14,000 | 404,961 (Direct) |
View |
2025-02-06 Sale |
2025-02-07 8:30 pm |
Applied Therapeutics Inc. | APLT | Perfetti Riccardo Chief Medical Officer |
86,078 | $0.61 | $52,508 | 900,775 (Direct) |
View |
2025-02-06 Sale |
2025-02-07 8:30 pm |
Applied Therapeutics Inc. | APLT | Chinoporos Constantine See Remarks |
28,117 | $0.61 | $17,151 | 271,883 (Direct) |
View |
2024-08-22 Sale |
2024-08-23 4:35 pm |
Applied Therapeutics Inc. | APLT | Funtleyder Leslie D. Chief Financial Officer |
13,530 | $5.83 | $78,880 | 277,911 (Direct) |
View |
2024-08-22 Sale |
2024-08-23 4:33 pm |
Applied Therapeutics Inc. | APLT | Perfetti Riccardo Chief Medical Officer |
22,681 | $5.83 | $132,230 | 986,853 (Direct) |
View |
2024-08-12 Sale |
2024-08-14 7:01 pm |
Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO |
777,014 | $6.0643 | $4,712,049 | 7,309,496 (Indirect Direct) |
View |
2024-06-06 Sale |
2024-06-10 4:29 pm |
Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner |
61,795 | $4.32 | $266,954 | 8,086,510 (Indirect Direct) |
View |
2024-06-06 Sale |
2024-06-10 4:28 pm |
Applied Therapeutics Inc. | APLT | Perfetti Riccardo Chief Medical Officer |
22,003 | $4.32 | $95,053 | 1,009,534 (Direct) |
View |
2024-06-06 Sale |
2024-06-10 4:25 pm |
Applied Therapeutics Inc. | APLT | Funtleyder Leslie D. Chief Financial Officer |
16,980 | $4.32 | $73,354 | 291,441 (Direct) |
View |
2024-06-04 Sale |
2024-06-06 6:45 pm |
Applied Therapeutics Inc. | APLT | ALEXANDRIA REAL ESTATE EQUITIES INC. Alexandria Venture Investments LLC Alexandria Equities No. 7 LLC 10% Owner |
300,000 | $4.225 | $1,267,500 | 6,059,054 (Indirect) |
View |
2024-03-14 Sale |
2024-03-18 6:12 pm |
Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner |
318,573 | $5.39 | $1,717,108 | 8,148,305 (Indirect Direct) |
View |
2024-03-14 Sale |
2024-03-18 6:02 pm |
Applied Therapeutics Inc. | APLT | Perfetti Riccardo Chief Medical Officer |
110,804 | $5.39 | $597,234 | 1,031,537 (Direct) |
View |
2024-03-14 Sale |
2024-03-18 6:00 pm |
Applied Therapeutics Inc. | APLT | Hansard Adam Chief Commercial Officer |
48,871 | $5.39 | $263,415 | 732,919 (Direct) |
View |
2024-03-14 Sale |
2024-03-18 5:57 pm |
Applied Therapeutics Inc. | APLT | Funtleyder Leslie D. Chief Financial Officer |
28,727 | $5.39 | $154,839 | 308,421 (Direct) |
View |
2023-12-01 Purchase |
2023-12-05 7:03 pm |
Applied Therapeutics Inc. | APLT | Kanter Stacy J. Director |
30,000 | $2.1789 | $65,367 | 63,000 (Direct) |
View |
2023-11-30 Sale |
2023-12-01 7:42 pm |
Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner |
3,968 | $1.97 | $7,817 | 6,926,878 (Indirect Direct) |
View |
2023-11-30 Sale |
2023-12-01 7:42 pm |
Applied Therapeutics Inc. | APLT | Perfetti Riccardo Chief Medical Officer |
1,583 | $1.97 | $3,119 | 692,341 (Direct) |
View |
2023-11-30 Sale |
2023-12-01 7:42 pm |
Applied Therapeutics Inc. | APLT | Hansard Adam Chief Commercial Officer |
965 | $1.97 | $1,901 | 381,790 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-03-24 Option Award |
2025-03-26 8:25 pm |
N/A N/A |
Applied Therapeutics Inc. | APLT | Hooks Corwin Dale Chief Commercial Officer |
250,000 | $0 | 550,000 (Direct) |
View |
2025-03-24 Option Award |
2025-03-26 8:21 pm |
N/A N/A |
Applied Therapeutics Inc. | APLT | Funtleyder Leslie D. See Remarks |
350,000 | $0 | 740,459 (Direct) |
View |
2025-03-24 Option Award |
2025-03-26 8:14 pm |
N/A N/A |
Applied Therapeutics Inc. | APLT | Chinoporos Constantine See Remarks |
350,000 | $0 | 621,436 (Direct) |
View |
2024-12-19 Option Award |
2024-12-20 8:30 pm |
N/A 2034-12-19 |
Applied Therapeutics Inc. | APLT | JOHNSON JOHN Executive Chairman |
1,500,000 | $0 | 1,500,000 (Direct) |
View |
2024-12-19 Option Award |
2024-12-20 8:30 pm |
N/A 2034-12-19 |
Applied Therapeutics Inc. | APLT | Funtleyder Leslie D. See Remarks |
150,000 | $0 | 577,911 (Direct) |
View |
2024-08-05 Gift |
2024-08-14 7:01 pm |
N/A N/A |
Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO |
1,495,772 | $0 | 7,309,496 (Indirect) |
View |
2024-06-06 Option Award |
2024-06-07 4:17 pm |
N/A N/A |
Applied Therapeutics Inc. | APLT | Kanter Stacy J. Director |
45,000 | $0 | 108,000 (Direct) |
View |
2024-06-06 Option Award |
2024-06-07 4:13 pm |
N/A N/A |
Applied Therapeutics Inc. | APLT | SKYLER JAY S Director |
45,000 | $0 | 65,000 (Direct) |
View |
2024-06-06 Option Award |
2024-06-07 4:12 pm |
N/A N/A |
Applied Therapeutics Inc. | APLT | MARCUS JOEL S Director |
45,000 | $0 | 498,414 (Direct) |
View |
2024-06-06 Option Award |
2024-06-07 4:07 pm |
N/A N/A |
Applied Therapeutics Inc. | APLT | Lerner Teena Director |
45,000 | $0 | 105,422 (Direct) |
View |
2024-04-12 Option Award |
2024-04-15 5:30 pm |
N/A N/A |
Applied Therapeutics Inc. | APLT | Hooks Corwin Dale Chief Commercial Officer |
300,000 | $0 | 300,000 (Direct) |
View |
2023-12-28 Option Award |
2024-03-18 5:51 pm |
N/A N/A |
Applied Therapeutics Inc. | APLT | Chinoporos Constantine See Remarks |
300,000 | $0 | 300,000 (Direct) |
View |
2023-12-21 Option Award |
2023-12-22 8:01 pm |
N/A N/A |
Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner |
1,540,000 | $0 | 8,466,878 (Direct) |
View |
2023-12-21 Option Award |
2023-12-22 8:01 pm |
N/A N/A |
Applied Therapeutics Inc. | APLT | Perfetti Riccardo Chief Medical Officer |
450,000 | $0 | 1,142,341 (Direct) |
View |
2023-12-21 Option Award |
2023-12-22 8:01 pm |
N/A N/A |
Applied Therapeutics Inc. | APLT | Hansard Adam Chief Commercial Officer |
400,000 | $0 | 781,790 (Direct) |
View |
2023-11-29 Other |
2023-12-01 6:53 pm |
N/A N/A |
Applied Therapeutics Inc. | APLT | ALEXANDRIA REAL ESTATE EQUITIES INC. Alexandria Equities No. 7 LLC Alexandria Venture Investments LLC 10% Owner |
575,000 | $0 | 1,353,977 (Indirect) |
View |
2023-11-20 Option Award |
2023-11-20 4:41 pm |
N/A N/A |
Applied Therapeutics Inc. | APLT | Funtleyder Leslie D. Chief Financial Officer |
300,000 | $0 | 337,148 (Direct) |
View |